Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com

Investing.com — Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:) to “overweight” from “equal weight,” raising its price…

Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program

SHANGHAI, Jan. 6, 2025 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a leading global biopharmaceutical company…

China approves Eli Lilly’s Alzheimer’s treatment Kisunla By Investing.com

INDIANAPOLIS – Eli Lilly and Company (NYSE: NYSE:), a pharmaceutical giant with a market capitalization of…